CRSP logo

CRSP
CRISPR Therapeutics AG

41,520
Mkt Cap
$5.23B
Volume
1.34M
52W High
$78.48
52W Low
$30.04
PE Ratio
-9.83
CRSP Fundamentals
Price
$54.84
Prev Close
$54.74
Open
$54.90
50D MA
$59.34
Beta
1.56
Avg. Volume
2.6M
EPS (Annual)
-$4.34
P/B
2.69
Rev/Employee
$94,946.57
Loading...
Loading...
News
all
press releases
CRISPR Therapeutics AG (CRSP) Falls More Steeply Than Broader Market: What Investors Need to Know
In the most recent trading session, CRISPR Therapeutics AG (CRSP) closed at $54.74, indicating a -2.2% shift from the previous trading day.
Zacks·1d ago
News Placeholder
More News
News Placeholder
Marex Group plc Invests $948,000 in CRISPR Therapeutics AG $CRSP
Marex Group plc purchased a new stake in shares of CRISPR Therapeutics AG (NASDAQ:CRSP - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the...
MarketBeat·4d ago
News Placeholder
Nikko Asset Management Americas Inc. Sells 125,618 Shares of CRISPR Therapeutics AG $CRSP
Nikko Asset Management Americas Inc. decreased its stake in shares of CRISPR Therapeutics AG (NASDAQ:CRSP - Free Report) by 4.9% during the second quarter, according to its most recent filing with...
MarketBeat·5d ago
News Placeholder
CRISPR Therapeutics AG (NASDAQ:CRSP) Receives Consensus Recommendation of "Hold" from Analysts
Shares of CRISPR Therapeutics AG (NASDAQ:CRSP - Get Free Report) have been assigned a consensus recommendation of "Hold" from the twenty-one ratings firms that are presently covering the company...
MarketBeat·6d ago
News Placeholder
New York State Common Retirement Fund Increases Position in CRISPR Therapeutics AG $CRSP
New York State Common Retirement Fund grew its stake in shares of CRISPR Therapeutics AG (NASDAQ:CRSP - Free Report) by 2,033.6% in the 2nd quarter, according to its most recent disclosure with the...
MarketBeat·8d ago
News Placeholder
Why Is CRISPR Therapeutics (CRSP) Up 3.3% Since Last Earnings Report?
CRISPR Therapeutics (CRSP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·9d ago
News Placeholder
Guggenheim Capital LLC Sells 37,778 Shares of CRISPR Therapeutics AG $CRSP
Guggenheim Capital LLC lowered its position in shares of CRISPR Therapeutics AG (NASDAQ:CRSP - Free Report) by 39.2% in the 2nd quarter, according to its most recent Form 13F filing with the...
MarketBeat·10d ago
News Placeholder
Norges Bank Invests $19.77 Million in CRISPR Therapeutics AG $CRSP
Norges Bank acquired a new stake in shares of CRISPR Therapeutics AG (NASDAQ:CRSP - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities...
MarketBeat·10d ago
News Placeholder
State Board of Administration of Florida Retirement System Acquires New Holdings in CRISPR Therapeutics AG $CRSP
State Board of Administration of Florida Retirement System bought a new position in CRISPR Therapeutics AG (NASDAQ:CRSP - Free Report) in the 2nd quarter, according to its most recent Form 13F filing...
MarketBeat·12d ago
News Placeholder
50,250 Shares in CRISPR Therapeutics AG $CRSP Purchased by Philadelphia Trust Co.
Philadelphia Trust Co. bought a new stake in CRISPR Therapeutics AG (NASDAQ:CRSP - Free Report) during the second quarter, according to its most recent filing with the Securities and Exchange...
MarketBeat·14d ago
<
1
2
...
>

Latest CRSP News

View

Advertisement|Remove ads.

Advertisement|Remove ads.